Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Dexcom Q1 2026 Earnings Call - Revenue Growth Accelerates on Type 2 Non-Insulin Coverage Wins and G7 15-Day Launch
Dexcom delivered a strong first quarter, with revenue growing 15% to $1.19 billion and organic growth of 12%. The company benefited from broader reimbursement access, particularly in the type 2 non-in...
- Dexcom reported Q1 2026 revenue of $1.19 billion, up 15% year-over-year, with organic growth of 12% after adjusting for foreign exchange and acquisitions/divestitures.
- U.S. revenue grew 11% to $832 million, driven by strong momentum in the type 2 non-insulin population and the launch of the G7 15-Day system.
- International revenue surged 26% to $360 million, with organic growth of 17%, fueled by recent reimbursement wins in markets like France and Canada.
- +7 more takeaways
Amgen Q1 2026 Earnings Call - MariTide Pivot to Less-Frequent Dosing Signals Bold Obesity Strategy
Amgen delivered a strong first quarter in 2026, with sales up 4% and six key growth drivers accounting for 70% of revenue. The company raised its full-year guidance, citing momentum across its diversi...
- Amgen reported 4% year-over-year product sales growth in Q1 2026, with six key growth drivers generating 70% of sales and growing 24% year-over-year.
- Management raised full-year 2026 guidance, projecting revenues of $37.1 billion to $38.5 billion and non-GAAP EPS of $21.70 to $23.10.
- MariTide, Amgen’s obesity and diabetes candidate, will undergo new Phase III studies evaluating switching from weekly GLP-1s to every 8-week or quarterly dosing.
- +12 more takeaways
Allegiant Travel Company Q1 2026 Earnings Call - Margin Expansion Defies Fuel Shock, Sun Country Close Imminent
Allegiant delivered a historic first quarter, posting a 14.9% adjusted operating margin and record revenue growth despite a 5.9% reduction in capacity. The airline’s disciplined focus on peak-day flyi...
- Adjusted operating margin expanded to 14.9%, marking the highest first-quarter margin in company history and outperforming guidance by nearly 6 percentage points year-over-year.
- Total revenue reached $732.4 million, a 9.6% year-over-year increase, driven by a 16.4% surge in TRASM despite a 5.9% reduction in available seat miles.
- Operational reliability remained elite with a 99.9% controllable completion factor, even amid winter weather disruptions and a higher mix of peak-day flying.
- +7 more takeaways
Stryker Q1 2026 Earnings Call - Cyber Incident Distorts Results But Full-Year Guidance Stands Firm
Stryker’s Q1 2026 results were heavily distorted by a late-quarter cyber incident that disrupted global manufacturing and delayed revenue recognition. Despite the operational shock, underlying demand ...
- Q1 2026 organic sales growth was 2.4% globally, with 1.9% in the U.S. and 3.9% internationally, significantly impacted by a late-quarter cyber incident.
- The cyber incident caused global operational disruptions, delaying revenue recognition and shipments, but manufacturing was fully operational by early April.
- Stryker reaffirmed its full-year 2026 guidance: 8%-9.5% organic sales growth and $14.90-$15.10 adjusted EPS, expecting most lost sales to be recovered throughout the year.
- +12 more takeaways
SanDisk Q3 2026 Earnings Call - NAND Business Transformed by Multi-Year Customer Contracts
SanDisk delivered a seismic quarter that redefines how the NAND industry operates. Revenue surged 97% sequentially to $5.95 billion, driven by a 233% jump in data center sales and a massive 78.4% non-...
- Revenue surged 97% sequentially to $5.95 billion and 251% year-over-year, significantly beating guidance of $4.4-4.8 billion, driven by pricing power and a mix shift toward high-value data center workloads.
- Data center revenue exploded 233% sequentially to $1.47 billion, reflecting strong demand for high-performance enterprise SSDs and positioning AI inference as a primary growth engine for NAND.
- SanDisk signed five multi-year New Business Model (NBM) contracts, securing $42 billion in minimum contractual revenue and over $11 billion in financial guarantees, fundamentally de-risking the business from cyclical spot pricing.
- +7 more takeaways
Reddit Q1 2026 Earnings Call - Revenue Growth Accelerates as AI Licensing and Ad Automation Drive Profitability
Reddit reported a blistering Q1 2026, with revenue jumping 69% year-over-year to $663 million and advertising revenue surging 74% to $625 million. The company achieved a 40% adjusted EBITDA margin and...
- Revenue grew 69% year-over-year to $663 million, with advertising revenue surging 74% to $625 million, marking the seventh consecutive quarter of over-60% growth.
- Adjusted EBITDA margin reached 40%, up nearly 1,100 basis points year-over-year, while GAAP EPS hit $1.01, more than seven times the prior year.
- Free cash flow margin stood at 47%, underscoring Reddit’s capital-light model with just $1 million in capital expenditures for the quarter.
- +7 more takeaways
Zeta Global Q1 2026 Earnings Call - Athena Drives Revenue Beat and Raised Guidance
Zeta Global delivered its 19th consecutive beat and raise quarter, with Q1 revenue of $396 million, up 50% year-over-year, and adjusted EBITDA of $66 million, up 42% year-over-year. The company raised...
- Zeta Global reported Q1 2026 revenue of $396 million, up 50% year-over-year, and adjusted EBITDA of $66 million, up 42% year-over-year, marking its 19th consecutive beat and raise quarter.
- The company raised its full-year 2026 revenue guidance by $30 million to $1.785 billion, representing a 37% growth rate, and raised adjusted EBITDA guidance to $397 million.
- Athena, Zeta's AI assistant, is driving significant platform adoption, with 60% of AI usage on the platform now attributed to it and a 7x increase in agentic interactions in its first week of general availability.
- +7 more takeaways
ResMed Q3 FY2026 Earnings Call - Fabric Mask Innovation and GLP-1 Tailwinds Drive Margin Expansion and Share Gains
ResMed delivered another quarter of disciplined execution, posting 11% headline revenue growth and 21% non-GAAP EPS growth, driven by strong mask resupply demand and gross margin expansion. The compan...
- ResMed reported Q3 FY2026 revenue of $1.43 billion, up 11% year-over-year, with constant currency growth of 8%.
- Non-GAAP diluted EPS grew 21%, reflecting strong operating leverage and margin expansion.
- Gross margin expanded 290 basis points year-over-year to 62.8%, driven by component cost improvements and logistics efficiencies.
- +7 more takeaways
Smithfield Foods Q1 2026 Earnings Call - Record Operating Profit Driven by Packaged Meats Momentum and Vertical Integration
Smithfield Foods delivered record first-quarter adjusted operating profit of $339 million, a 4% year-over-year increase, powered by disciplined execution across its vertically integrated model. Packag...
- Record first quarter adjusted operating profit of $339 million, up 4% year-over-year, with an adjusted operating profit margin of 8.9%.
- Packaged Meats operating profit reached $275 million, up 4% from the prior year, driven by a 3.5% volume increase and a 2.6% rise in average sales price.
- The company is actively shifting its product mix toward higher-margin, value-added categories, such as lunch meat and dry sausage, which saw unit growth of 11.1% and 10% respectively.
- +7 more takeaways
Schneider National Q1 2026 Earnings Call - Supply Attrition Drives Early Cycle Momentum Amid Macro Headwinds
Schneider National reported a resilient Q1 2026 performance despite severe weather disruptions, driven by a structural supply rationalization that is forcing capacity out of the market faster than exp...
- Supply Rationalization Accelerates: Management cites regulatory actions (DOT safety enforcement, CDL mill crackdowns) and fuel cost inflation as primary drivers forcing capacity out of the market faster than anticipated, creating a structurally tighter freight environment.
- Network Productivity Surges: Revenue per truck per week in the Network segment grew 7% year-over-year, with the majority of gains stemming from productivity improvements rather than price increases, marking the strongest March performance since 2023.
- Spot Exposure Yields Early Gains: Schneider purposefully increased its spot exposure to nearly double historical levels during the down cycle, capturing accretive rates in February and March and providing a buffer against contract rate stagnation.
- +7 more takeaways